Why the study?
The role of transglutaminase 2 in myocardial infarction and the mechanisms underlying macrophage polarization were unclear.
Does Transglutaminase 2 (TG2) inhibition ameliorate cardiac fibrosis in myocardial infarction models?
Does Transglutaminase 2 (TG2) inhibition ameliorate cardiac fibrosis in myocardial infarction models?
TG2 inhibition protects against post-MI cardiac fibrosis in mice by promoting M2 macrophage polarization, likely via the TGF-β1/Smad3 pathway.
Answers are grounded in this paper and cite their sources.
TG2 inhibition merits further study to limit post-MI fibrosis; hypothesis-generating in mice and should not change practice.
Objective: Macrophages perform vital functions in cardiac remodeling after myocardial infarction (MI). Transglutaminase 2 (TG2) participates in fibrosis. Nevertheless, the role of TG2 in MI and mechanisms underlying macrophage polarization are unclear. This study aimed to discover the functions and possible mechanisms of TG2 in MI. Material and Methods: study involved the treatment of mouse cardiac fibroblasts isolated from mice with transforming growth factor β1 (TGF-β1) and evaluation of fibrosis through the detection of the expressions of fibrosis-associated proteins using Western blot. Bone marrow-derived macrophages (BMDMs) obtained from mice were triggered by interleukin (IL)-4, and the type of macrophages was determined through flow cytometry. Moreover, TG2 inhibition remarkably increased M2 macrophage polarization in IL-4-induced BMDMs. Conclusion: TG2 inhibition facilitated M2 macrophage polarization to provide protection against MI-caused cardiac fibrosis in mice, and these effects may be attained through modulation of the TGF-β1/Smad3 pathway.
No takes yet. Share an insight, caveat, or question.
Maimaitijiang et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: